Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

Core Insights - Hydreight Technologies Inc. reported a 132% year-over-year revenue increase in Q3 2025, marking its fourth consecutive quarter of profitability, driven by a diversified multi-vertical business model [3][6][23] Financial Performance - Q3 2025 GAAP revenue reached $10.52 million, a 132% increase compared to Q3 2024 - Topline revenue for Q3 was $12.83 million, up 110% year-over-year - Gross margin for Q3 was $2.33 million, an increase from $1.53 million in Q3 2024 - Adjusted EBITDA for Q3 was $620K, indicating continued operational improvement - GAAP net income for Q3 was $362K, compared to a net loss of $90K in Q3 2024 - For the first nine months of 2025, topline revenue was $26.71 million, up 61% year-over-year, and GAAP revenue was $20.44 million, up 70% year-over-year [6][8][23] Business Model and Growth - Hydreight operates a multi-vertical platform, with GLP-1 treatments accounting for approximately 28% of total platform activity, indicating a balanced and diversified approach [3][4] - The company has seen a 72% year-over-year increase in pharmacy orders, reflecting strong demand and treatment continuity [9] - The nurse network and clinic engagement have shown significant growth, with 198 new nurse sign-ups in Q3 2025, a 49% increase year-over-year [15] VSDHOne Platform - VSDHOne, launched in June 2025, has recorded approximately 295,000 product orders in Q3 and a total of about 887,000 orders since its launch [11][12] - The company aims to reach a target of approximately 1.3 million product orders for 2025, based on existing partner demand [13] Strategic Initiatives - The company is focused on enhancing its operational infrastructure, compliance, and automation processes as part of its 2026 framework [20][22] - Hydreight is expanding into additional treatment categories, including genetics and oral weight management, while also growing its partner ecosystem across the United States [22] Future Outlook - The company plans to release its 2026 guidance in mid-December, with a focus on stability, scale, and continued engagement with shareholders [23]